Semaphorin 3A Disrupts Endothelial Structure and Lysosomal Function: In Vitro Mechanisms and In Vivo Evidence in Hypertensive Pregnancy
Clinical Science · 2026
DOI: 10.1042/cs20258480 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, 2026. Verfasst von Gabriella Ferretti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Pharmacology, Department of Neuroscience, School of Medicine, University of Naples, "Federico II", 80131 Naples, Italy. Hauptthemen laut MEDLINE: Semaphorin-3A, Lysosomes, Hypertension, Pregnancy-Induced, Endothelial Cells. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca.
Abstract (Originalsprache)
Semaphorin 3A (SEMA3A), a neurovascular guidance molecule, is increasingly recognized for its roles in angiogenesis and immune regulation, yet its impact on vascular dysfunction during pregnancy remains uncertain. We examined circulating and placental SEMA3A levels in women with healthy pregnancies, those with hypertensive disorders of pregnancy with appropriate-for-gestational-age fetuses, and hypertensive pregnancies complicated by fetal growth restriction, supplementing these analyses with in vitro endothelial assays. In maternal plasma and placental tissues, SEMA3A levels were elevated in hypertensive pregnancies, peaking in cases with fetal growth restriction. In cultured endothelial cells, SEMA3A disrupted cytoskeletal organization, compromised barrier stability, and altered cellular morphology. These changes were linked to lysosomal accumulation of its receptor Neuropilin-1 and altered lysosomal function. Collectively, these findings identify SEMA3A as a regulator of endothelial cytoskeletal and lysosomal dynamics. By connecting in vitro mechanistic studies with in vivo pregnancy samples, this work underscores a novel role for SEMA3A that may be pertinent to hypertensive pregnancy and its complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Pharmacology, Department of Neuroscience, School of Medicine, University of Naples, "Federico II", 80131 Naples, Italy.
- Department of Medicine and Health Sciences, Centre for Research and Training in Medicine of Aging, University of Molise, 86100 Campobasso, Italy.
- Unit of Gynecology, Department of Neuroscience, School of Medicine, University of Naples, "Federico II", 80131 Naples, Italy.
ORCID-Profile: Gabriella Ferretti, Sara Serafini, Carmela Matrone
Förderung
- Ministero dell'Università e della Ricerca
Zitieren
APA
Ferretti, G., Serafini, S., Sarno, L., Palese, M., Abbruzzese, A., Di Palo, F. R., De Simone, C., Guida, M., & Matrone, C. (2026). Semaphorin 3A Disrupts Endothelial Structure and Lysosomal Function: In Vitro Mechanisms and In Vivo Evidence in Hypertensive Pregnancy. Clinical Science. https://doi.org/10.1042/cs20258480
Vancouver
Ferretti G, Serafini S, Sarno L, Palese M, Abbruzzese A, Di Palo FR, et al. Semaphorin 3A Disrupts Endothelial Structure and Lysosomal Function: In Vitro Mechanisms and In Vivo Evidence in Hypertensive Pregnancy. Clinical Science. 2026. doi:10.1042/cs20258480
BibTeX
@article{Ferretti2026,
author = {Ferretti, Gabriella and Serafini, Sara and Sarno, Laura and Palese, Michela and Abbruzzese, Antonella and Di Palo, Francesca R and De Simone, Concetta and Guida, Maurizio and Matrone, Carmela},
title = {Semaphorin 3A Disrupts Endothelial Structure and Lysosomal Function: In Vitro Mechanisms and In Vivo Evidence in Hypertensive Pregnancy},
journal = {Clinical Science},
year = {2026},
doi = {10.1042/cs20258480}
}
EUVIMED